502 related articles for article (PubMed ID: 22441145)
41. Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibition.
van Houdt WJ; de Bruijn MT; Emmink BL; Raats D; Hoogwater FJ; Borel Rinkes IH; Kranenburg O
Cell Oncol; 2010 Jan; 32(4):245-57. PubMed ID: 20413844
[TBL] [Abstract][Full Text] [Related]
42. Ras/MEK/ERK Up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-beta suppression of myogenesis.
Peña TL; Chen SH; Konieczny SF; Rane SG
J Biol Chem; 2000 May; 275(18):13677-82. PubMed ID: 10788486
[TBL] [Abstract][Full Text] [Related]
43. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
Yip-Schneider MT; Schmidt CM
Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
[TBL] [Abstract][Full Text] [Related]
44. Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines.
Marampon F; Gravina GL; Popov VM; Scarsella L; Festuccia C; La Verghetta ME; Parente S; Cerasani M; Bruera G; Ficorella C; Ricevuto E; Tombolini V; Di Cesare E; Zani BM
Int J Oncol; 2014 Jan; 44(1):285-94. PubMed ID: 24189697
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen.
Richards JD; Davé SH; Chou CH; Mamchak AA; DeFranco AL
J Immunol; 2001 Mar; 166(6):3855-64. PubMed ID: 11238629
[TBL] [Abstract][Full Text] [Related]
46. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
[TBL] [Abstract][Full Text] [Related]
47. Transcriptional regulation of the small GTPase RhoB gene by TGF{beta}-induced signaling pathways.
Vasilaki E; Papadimitriou E; Tajadura V; Ridley AJ; Stournaras C; Kardassis D
FASEB J; 2010 Mar; 24(3):891-905. PubMed ID: 19890017
[TBL] [Abstract][Full Text] [Related]
48. Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells.
Lee S; Heinrich EL; Lu J; Lee W; Choi AH; Luu C; Chung V; Fakih M; Kim J
Pancreas; 2016 Feb; 45(2):286-92. PubMed ID: 26262587
[TBL] [Abstract][Full Text] [Related]
49. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
Anders M; Christian C; McMahon M; McCormick F; Korn WM
Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824
[TBL] [Abstract][Full Text] [Related]
51. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
52. Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines.
Li H; Schmid-Bindert G; Wang D; Zhao Y; Yang X; Su B; Zhou C
Adv Med Sci; 2011; 56(2):275-84. PubMed ID: 22037177
[TBL] [Abstract][Full Text] [Related]
53. Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways.
Shen X; Artinyan A; Jackson D; Thomas RM; Lowy AM; Kim J
Pancreas; 2010 Jan; 39(1):81-7. PubMed ID: 19820417
[TBL] [Abstract][Full Text] [Related]
54. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells.
Chow JY; Quach KT; Cabrera BL; Cabral JA; Beck SE; Carethers JM
Carcinogenesis; 2007 Nov; 28(11):2321-7. PubMed ID: 17638924
[TBL] [Abstract][Full Text] [Related]
55. Ras-MEK-ERK signaling cascade regulates androgen receptor element-inducible gene transcription and DNA synthesis in prostate cancer cells.
Carey AM; Pramanik R; Nicholson LJ; Dew TK; Martin FL; Muir GH; Morris JD
Int J Cancer; 2007 Aug; 121(3):520-7. PubMed ID: 17415712
[TBL] [Abstract][Full Text] [Related]
56. Induction of MAP kinase phosphatase 3 through Erk/MAP kinase activation in three oncogenic Ras (H-, K- and N-Ras)-expressing NIH/3T3 mouse embryonic fibroblast cell lines.
Koo J; Wang S; Kang N; Hur SJ; Bahk YY
BMB Rep; 2016 Jul; 49(7):370-5. PubMed ID: 26818088
[TBL] [Abstract][Full Text] [Related]
57. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
Iglesias M; Frontelo P; Gamallo C; Quintanilla M
Oncogene; 2000 Aug; 19(36):4134-45. PubMed ID: 10962574
[TBL] [Abstract][Full Text] [Related]
58. Fcgamma receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction.
Song X; Tanaka S; Cox D; Lee SC
J Leukoc Biol; 2004 Jun; 75(6):1147-55. PubMed ID: 14982949
[TBL] [Abstract][Full Text] [Related]
59. MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma.
Marampon F; Bossi G; Ciccarelli C; Di Rocco A; Sacchi A; Pestell RG; Zani BM
Mol Cancer Ther; 2009 Mar; 8(3):543-51. PubMed ID: 19258428
[TBL] [Abstract][Full Text] [Related]
60. Nobiletin induces inhibitions of Ras activity and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling to suppress cell proliferation in C6 rat glioma cells.
Aoki K; Yokosuka A; Mimaki Y; Fukunaga K; Yamakuni T
Biol Pharm Bull; 2013; 36(4):540-7. PubMed ID: 23546290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
